Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.

NCT01791101 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT01791101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Phase 2
Overall status
Completed
Start date
September 16, 2013
Completion date
June 26, 2020
Enrollment
10 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia